Literature DB >> 25131055

Ischemic preconditioning and atenolol on lung injury after intestinal ischemia and reperfusion in rats.

W G S Bonservizi1, M K Koike2, R Saurim1, G A A Felix1, S M da Silva1, E F S Montero3, M O Taha1.   

Abstract

The aim of this study was evaluate the beta blocker atenolol (AT) and ischemic preconditioning (IPC) strategies for tissue protection against systemic effects of intestinal ischemia (I) and reperfusion (R) injury. Forty-two rats were pretreated with AT (1.5 mg · kg(-1)), 0.9% saline solution (SS; 0.1 mL), or IPC and then subjected to prolonged occlusion of the superior mesenteric artery for 60 minutes leading to I followed or not by 120 minutes of R, according to the group. For IPC, 5 minutes of I prior to 10 minutes of R were established. After this process of I or I-R, the right lung of each animal was adequately prepared for staining with hematoxylin and eosin and subsequent histologic analysis for quantification of inflammatory infiltrate was done. The left lung was frozen and prepared for assessment of oxidative stress by the quantification of thiobarbituric acid-reactivity substances (TBARS). Histologic analysis showed an important inflammatory infiltrate in the I-R + SS (I-R + SS = 4.5), which was significantly (P < .05) reduced by IPC (I-R + IPC = 3.0) or AT (I-R + AT = 3.0). Likewise, the TBARS levels were decreased by both strategies (I-R + SS = 0.63; I-R + IPC = 0.23; I-R + AT = 0.38; P < .05). Our results showed that AT and IPC attenuate pulmonary lesions caused by intestinal I and R process.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25131055     DOI: 10.1016/j.transproceed.2014.05.054

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

Review 1.  Oxidative Stress and Lung Ischemia-Reperfusion Injury.

Authors:  Renata Salatti Ferrari; Cristiano Feijó Andrade
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

Review 2.  Puerarin: A protective drug against ischemia-reperfusion injury.

Authors:  Minglang Gao; Ziyao Zhang; Kai Lai; Yu Deng; Chuanbing Zhao; Zilong Lu; Qing Geng
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.